Tulrampator

DB16344InvestigationalSmall molecule

Tulrampator is under investigation in clinical trial NCT02626572 (Efficacy and Safety of 3 Doses of S47445 Versus Placebo in Patients With Alzheimer's Disease at Mild to Moderate Stages With Depressive...

Mechanism: Pharmacologically active on Glutamate receptor 2 and Glutamate receptor 4
Curator reviewed
Formula / weight: C₂₀H₁₇FN₄O₃ · 380.379 g/mol (avg)
Code names: CX1632 · S47445

Resolves to

Compound

UNII7633T9D4LNCAS1038984-31-4ChEMBLCHEMBL1276826

Structure

InChIKeyJHCFQXNWYDLBOG-UHFFFAOYSA-NSMILESFC1=CC=CC(CCN2N=NC3=CC4=C(OCN(C5CC5)C4=O)C=C3C2=O)=C1

Targets

P42262GRIA2P48058GRIA4

What you can answer from here — as of July 08, 2026

2Protein targetsEach mapped to UniProt, with action and pharmacological action

Listed above

2Clinical trialsPhase, status and sponsor resolved per trial

2+ReferencesStructured and connected to the statements they support

Which drugs share a target with Tulrampator, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account